We hope you’ve found some canine osteoarthritis (OA) cases to start on Daxocox®, the first and only weekly oral NSAID for OA in dogs. If you have, we’d love to hear how you’re getting on, and in return we will give you another £250 worth of Daxocox® for free! Just provide us with some feedback in the ‘How did you get on?’ box below and put in your request for another £250 worth of Daxocox®.
Want to tell someone else about this great offer?
REFERENCES: 1. Daxocox® Pet Owner Insight Executive Summary (N=200) January 2021. 2. Internal report: DA/197/C, pending publication. 3. Salichs M., Badiella L., Sarasola P., Homedes J. (2021) Efficacy and safety of enflicoxib for treatment of canine osteoarthritis: A 6-week randomised, controlled, blind, multicentre clinical trial. Veterinary Record e949. https://doi.org/10.1002/vetr.949 4. Internal report: PK_001_2018, pending publication. 5. Daxocox® SPC
Daxocox®15mg, 30mg, 45mg, 70mg and 100mg weekly tablets for dogs. Active substance: Enflicoxib. UK POM-V, 15mg Vm 32742/5001 EU/2/21/270/001-007, 30mg Vm 32742/5002 EU/2/21/270/008-014, 45mg Vm 32742/5003 EU/2/21/270/015-021, 70mg Vm 32742/5004 EU/2/21/270/022-028, 100mg Vm 32742/5005 EU/2/21/270/029-035. Indications for use: For the treatment of pain and inflammation associated with osteoarthritis (or degenerative joint disease) in dogs. Further information can be found in the SPC, the datasheet or the pack leaflet.
USE MEDICINES RESPONSIBLY.
Terms and conditions : 1. Offer available in the United Kingdom only. 2. Animalcare reserve the right to withdraw the offer at any time. 3. Offer closes 31st December 2022. 4. Promotion and prices subject to change. 5. The initial trial offer is only available once per practice.
Daxocox® is a registered trademark of Animalcare Group Plc
Copyright ©2021 Animalcare. All rights reserved.